DIFFERENTIAL EXPRESSION OF METALLOPROTEINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE GENES IN AGED HUMAN FIBROBLASTS

被引:196
|
作者
MILLIS, AJT
HOYLE, M
MCCUE, HM
MARTINI, H
机构
[1] Center for Cellular Differentiation, Department of Biological Sciences, University at Albany, Albany, NY 12222
关键词
D O I
10.1016/0014-4827(92)90286-H
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The basal levels of mRNAs encoding two metalloproteinases, collagenase and stromelysin, were increased as a function of in vitro serial subcultivation (cellular aging) of human fibroblasts. Procollagenase and prostromelysin synthesis and secretion were also greater in the old cultures (late passage). In contrast, the steadystate expression of mRNA for an inhibitor of metalloproteinases, tissue inhibitor of metalloproteinase-1 (TIMP-1), in late-passage cultures was lower than that in young cell cultures (early passage). Each mRNA was analyzed using total RNA preparations isolated from normal fibroblast cultures at different phases of the in vitro life span and from cultures derived from donors with the premature senescence syndromes characterized as Werner syndrome, progeria (Hutchinson-Gilford) syndrome, or Cockayne syndrome. In normal cell cultures expression of metalloproteinase mRNAs was increased after the culture had completed >90% of the in vitro life span, and the reduction in TIMP-1 mRNA expression occurred after the culture had completed >74% of the in vitro lifespan. In Werner syndrome cultures expression of metalloproteinase and TIMP-1 mRNAs was similar to the level of expression observed in late-passage cell cultures. Levels of metalloproteinase and TIMP-1 mRNA expression in progeria and Cockayne syndromes were similar to those of early-passage cell cultures. To determine if young and old cells were each responsive to mediators of metalloproteinase synthesis, cultures were treated with phorbol ester or cytokines. 12-O-tetradecanoylphorbol-13-acetate treatment increased the steady-state levels of all three mRNAs in young, old, and Werner syndrome cultures and increased procollagenase levels in all cultures. Early- and late-passage cell cultures also responded to cytokines. Interleukin-1α treatment increased collagenase and stromelysin mRNA levels while transforming growth factor-β reduced the steady-state levels of both transcripts. Neither cytokine affected the steady-state level of TIMP-1 mRNA. The results indicate that in vitro cellular aging is associated with changes in expression of mRNAs encoding proteins that mediate inflammatory responses and connective tissue remodeling. © 1992.
引用
收藏
页码:373 / 379
页数:7
相关论文
共 50 条
  • [1] REGULATION OF METALLOPROTEINASE AND TISSUE INHIBITOR OF METALLOPROTEINASE LEVELS BY TGF-BETA IN AGED HUMAN FIBROBLASTS
    MASTRANGELO, LM
    MILLIS, AJT
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1992, 3 : A326 - A326
  • [2] Expression of matrix metalloproteinase, a disintegrin and metalloproteinase, and tissue inhibitor of metalloproteinase in human chondrosarcoma
    Sugita, H
    Osaka, S
    Toriyama, M
    Osaka, E
    Yoshida, Y
    Ryu, J
    Sano, M
    Sugitani, M
    Nemoto, N
    [J]. ACTA HISTOCHEMICA ET CYTOCHEMICA, 2004, 37 (05) : 319 - 323
  • [3] COORDINATE REGULATION OF MATRIX METALLOPROTEASES AND TISSUE INHIBITOR OF METALLOPROTEINASE EXPRESSION IN HUMAN SYNOVIAL FIBROBLASTS
    DIBATTISTA, JA
    PELLETIER, JP
    ZAFARULLAH, M
    FUJIMOTO, N
    OBATA, KI
    MARTELPELLETIER, J
    [J]. JOURNAL OF RHEUMATOLOGY, 1995, 22 : 123 - 128
  • [4] Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states
    Pagenstecher, A
    Stalder, AK
    Kincaid, CL
    Shapiro, SD
    Campbell, IL
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1998, 152 (03): : 729 - 741
  • [5] Differential expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 by human vascular smooth muscle cells
    Kato, S
    Yasukawa, H
    Fujii, T
    Miyagi, M
    Nishi, M
    Morimatsu, M
    Miyamoto, T
    Fox, JC
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 251 - 251
  • [6] Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate
    Hashimoto, K
    Kihira, Y
    Matuo, Y
    Usui, T
    [J]. JOURNAL OF UROLOGY, 1998, 160 (05): : 1872 - 1876
  • [7] Tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 expression in human amnion mesenchymal and epithelial cells
    Rowe, TF
    King, LA
    MacDonald, PC
    Casey, ML
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (04) : 915 - 921
  • [8] Matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in diabetic and venous ulcers
    Jude, EB
    Rogers, AA
    Oyibo, SO
    Armstrong, DG
    Boulton, AJM
    [J]. DIABETOLOGIA, 2001, 44 : A3 - A3
  • [9] Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-2 in human endometrial carcinoma
    陈梅
    薄乃秀
    黄亚军
    戴琪
    巩丽梅
    [J]. 生殖医学杂志, 2010, 19(S2) (S2) : 59 - 63
  • [10] REGULATION OF TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE EXPRESSION
    OVERALL, CM
    [J]. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 1994, 732 : 51 - 64